APA (7th ed.) Citation

Knoll, M., Balermpas, P., von der Grün, J., Tawk, B., Adeberg, S., Tinhofer, I., . . . Abdollahi, A. (2020). Superior Prognostic Performance of an Immunohistochemistry Trained DNA-Methylation Based PD-L1 Score in Patients with HNSCC Treated with Radiochemotherapy: A Multicenter Study of the German Cancer Consortium Radiation Oncology Group (DKTK-ROG). International Journal of Radiation Oncology, Biology, Physics, 108(3), S161. https://doi.org/10.1016/j.ijrobp.2020.07.925

Chicago Style (17th ed.) Citation

Knoll, M., et al. "Superior Prognostic Performance of an Immunohistochemistry Trained DNA-Methylation Based PD-L1 Score in Patients with HNSCC Treated with Radiochemotherapy: A Multicenter Study of the German Cancer Consortium Radiation Oncology Group (DKTK-ROG)." International Journal of Radiation Oncology, Biology, Physics 108, no. 3 (2020): S161. https://doi.org/10.1016/j.ijrobp.2020.07.925.

MLA (9th ed.) Citation

Knoll, M., et al. "Superior Prognostic Performance of an Immunohistochemistry Trained DNA-Methylation Based PD-L1 Score in Patients with HNSCC Treated with Radiochemotherapy: A Multicenter Study of the German Cancer Consortium Radiation Oncology Group (DKTK-ROG)." International Journal of Radiation Oncology, Biology, Physics, vol. 108, no. 3, 2020, p. S161, https://doi.org/10.1016/j.ijrobp.2020.07.925.